2024-11-13T16:38:33+00:00 2023-12-31 346565596 ERNST & YOUNG US LLP ONE MANHATTAN WEST NEW YORK NY 100018604 990 2023-01-01 237348742 The Transplantation Society TRAN 5148741717 740 NOTRE-DAME W SUITE 1245 Montreal Quebec CA H3X3X6 MARCELLE MCPHADEN EXECUTIVE DIRECTOR 5148741717 2024-11-13 true true Yucen Zhong P01593150 2127733000 2024-11-11 2023 2024-10-15 13:58:12Z MARCELLE MCPHADEN 740 NOTRE-DAME W SUITE 1245 Montreal Quebec CA H3X3X6 3030451 false X www.tts.org X 1972 DE INTERNATIONAL LEADERSHIP IN THE SCIENCE, EDUCATION, ETHICS AND PRACTICE OF TRANSPLANTATION. 20 20 0 62 0 0 691828 429727 3178991 1456528 369753 512422 0 15634 4240572 2414311 387186 336550 0 0 818648 805096 0 0 0 2805623 1448847 4011457 2590493 229115 -176182 12722154 13466690 1708273 1606109 11013881 11860581 THE TRANSPLANTATION SOCIETY PROVIDES THE FOCUS FOR GLOBAL LEADERSHIP IN TRANSPLANTATION FOR THE DEVELOPMENT OF THE SCIENCE AND CLINICAL PRACTICE, SCIENTIFIC COMMUNICATION, CONTINUING EDUCATION AND GUIDANCE ON THE ETHICAL PRACTICE. false false 679865 0 1057445 PROGRAM AND MAGAZINE PUBLICATIONS INCLUDING WEBSITE DEVELOPMENT AND WEBINARS AVAILABLE TO MEMBERS ONLY. THESE PUBLICATIONS RELATE SPECIFICALLY TO THE FIELD OF ORGAN TRANSPLANTATION. 336550 336550 0 SEE SCHEDULE O AN INTERNATIONAL FORUM FOR THE WORLD-WIDE ADVANCEMENT OF ORGAN TRANSPLANTATION INCLUDING A FOCUS ON - DEVELOPMENT OF THE SCIENCE AND CLINICAL PRACTICE - SCIENTIFIC COMMUNICATION - CONTINUING EDUCATION -GUIDANCE ON THE ETHICAL PRACTICE OF TRANSPLANTATION. THE ORGANIZATION ACHIEVES THIS FOCUS BY MAKING GRANTS TO SECTION AND REGIONAL SOCIETIES FOR THE PURPOSE OF TRAVEL, RESEARCH FELLOWSHIP, AND RECOGNIZING INDIVIDUALS WHO HAVE MADE OUTSTANDING CONTRIBUTIONS IN TRANSPLANTATION. THE PRIMARY AWARDS AND GRANTS ARE: 1) THE MEDAWAR PRIZE, NAMED AFTER SOCIETY CO-FOUNDER SIR PETER MEDAWAR, IS RECOGNIZED AS THE WORLD'S HIGHEST DEDICATED AWARD FOR THE MOST OUTSTANDING CONTRIBUTIONS IN THE FIELD OF TRANSPLANTATION. THE MEDAWAR PRIZE HAS BEEN AWARDED TO TWO OR MORE RECIPIENTS AT EACH OF THE ORGANIZATION'S BIENNIAL CONGRESSES SINCE 1990. THE AWARD IS MADE POSSIBLE BY A GENEROUS GRANT FROM NOVARTIS PHARMA AG WHO AGREED THAT A PRESTIGIOUS PRIZE BE ESTABLISHED AND MAINTAINED TO RECOGNIZE THE OUTSTANDING INVESTIGATORS WHOSE CONTRIBUTIONS HAVE HAD SUCH A PROFOUND INFLUENCE ON THE FIELD OF ORGAN TRANSPLANTATION. 2) TTS Thomas Starzl Innovation Award. Named after Tom Starzl who was best known for his contributions to the field of organ transplantation, and often referred to as the "father of transplantation". The award recognizes individuals who, though advanced and original work, have contributed significantly to transplantation, thereby reflecting the spirit pioneered by Dr. Starzl. 3) TTS RESEARCH FELLOWSHIPS ARE OFFERED FOR A PERIOD OF 2 YEARS TO SUPPORT BASIC AND CLINICAL RESEARCH IN THE FIELD OF TRANSPLANTATION IN THE LABORATORY OR CLINICAL UNIT OF A FULL TTS MEMBER. THE FELLOWSHIPS ARE DESIGNED TO PROVIDE RESEARCH TRAINING FOR NEW YOUNG INVESTIGATORS WITH THE POTENTIAL OF MAKING A SIGNIFICANT CONTRIBUTION TO THE FIELD OF TRANSPLANTATION. 4) TRAVEL GRANTS FOR YOUNG INVESTIGATORS AND FOR THOSE WITH FINANCIAL DIFFICULTIES WHO ARE MEMBERS OF THE ORGANIZATION. 509721 0 399083 SEE SCHEDULE O EVENTS HELD IN A VARIETY OF GLOBAL VENUES WHERE MEMBERS OF THE COMMUNITY ARE BROUGHT TOGETHER TO DISCUSS ADVANCEMENTS IN ORGAN TRANSPLANTATION. ORGAN TRANSPLANTATION IS A SUCCESSFUL THERAPY FOR END STAGE ORGAN FAILURE OF THE KIDNEY, LIVER, HEART, LUNG, PANCREAS AND INTESTINE. TRANSPLANTATION OF CELLS AND TISSUES ALSO TRANSFORMED THE THERAPEUTIC OPTIONS FOR PATIENTS WITH MALIGNANT HAEMATOLOGICAL DISEASE, EYE DISEASE AND ORTHOPAEDIC DISEASE, AND HAS THE POTENTIAL TO ALTER SIGNIFICANTLY THE THERAPEUTIC OPTIONS FOR PATIENTS WITH DIABETES AND A RANGE OF DISORDERS. THE ACCESS OF PATIENTS TO TRANSPLANTATION THERAPY VARIES WIDELY ACROSS THE GLOBE, PARTLY DETERMINED BY THE UNDERLYING LEVEL OF ECONOMIC DEVELOPMENT IN DIFFERENT STATES AND PARTLY DETERMINED BY OTHER FACTORS SUCH AS THE AVAILABILITY OF ORGAN, CELL AND TISSUE DONORS, OR THE SPECIALIZED PROVISION OF HEALTH SERVICES. THE ORGANIZATION HAS DETERMINED THAT IT WILL SEEK TO ADDRESS GLOBAL INEQUITIES IN TRANSPLANTATION THERAPY, IN ORDER TO FACILITATE APPROPRIATE ACCESS TO TRANSPLANTATION FOR ALL PATIENTS WHO WOULD BENEFIT. 1526136 true true false false false false false false false true false false false true false true false false true true true true false false false false true true false false false false false false false false false false false false false false false false false false true X 0 0 0 false true CA false false false false false false false false false false false false X 20 20 false false false false true true true true true false false true true true true false false true true false X DENISE RAINVILLE 5148741717 740 NOTRE-DAME STE 1245 Montreal Quebec CA H3C3X6 DR ELMI MULLER PRESIDENT 2.0 0.0 X X 0 0 0 DR JOHN FUNG PRESIDENT-ELECT 1.0 0.0 X X 0 0 0 DR MARCELO CANTAROVICH IMMDIATE PAST PRESIDENT 2.0 0.0 X X 0 0 0 GABRIEL E GONDOLESI Senior Treasurer 1.0 0.0 X X 0 0 0 Medhat Askar Treasurer 1.0 0.0 X X 0 0 0 RON SHAPIRO SECRETARY 1.0 0.0 X X 0 0 0 Stefan Tullius VICE-PRESIDENT 1.0 0.0 X X 0 0 0 CAMILLE N KOTTON COUNCILOR 0.5 0.0 X 0 0 0 CARLOS DIAZ COUNCILOR 0.5 0.0 X 0 0 0 CURRIE AHN COUNCILOR 0.5 0.0 X 0 0 0 David Thomson COUNCILOR 0.5 0.0 X 0 0 0 Dominique Martin COUNCILOR 0.5 0.0 X 0 0 0 DORRY SEGEV COUNCILOR 0.5 0.0 X 0 0 0 John Forsythe COUNCILOR 0.5 0.0 X 0 0 0 Jose Osmar Medina Pestana COUNCILOR 0.5 0.0 X 0 0 0 MARIA CRISTINA RIBEIRO DE CAS COUNCILOR 0.5 0.0 X 0 0 0 NADEY HAKIM COUNCILOR 0.5 0.0 X 0 0 0 Peter Stock COUNCILOR 0.5 0.0 X 0 0 0 RANDALL E MORRIS COUNCILOR 0.5 0.0 X 0 0 0 VIVEK KUTE COUNCILOR 0.5 0.0 X 0 0 0 MARCELLE MCPHADEN EXECUTIVE DIRECTOR 40.0 0.0 X 127870 0 0 127870 0 0 1 false false false John Wiley & Sons Inc 111 River Street Hoboken NJ 07030 Management editor for journal 181399 Wolters Kluwer Health Inc 2001 Market St Philadelphia PA 19103 Publisher of journal 122126 2 0 212277 0 0 0 217450 429727 Journals 511110 1057445 1057445 Management Fees 561000 329456 329456 Meetings and Registrations 911430 69627 69627 0 0 0 0 1456528 388872 388872 0 0 739690 616140 123550 0 123550 123550 Miscellaneous Income 900099 15634 15634 0 0 0 0 15634 2414311 1456528 0 528056 18000 18000 70900 70900 247650 247650 0 0 127870 127870 565582 85974 479608 56952 7522 49430 54692 7838 46854 191112 191112 1726 1726 27675 27675 54047 54047 0 0 0 0 12268 12268 52460 52460 61883 33322 28561 66464 66464 124435 46689 77746 137264 137264 29090 29090 5817 5817 Journals 679865 679865 Loss on FX 4148 4148 Business Taxes 593 593 0 0 0 0 2590493 1526136 1064357 0 2325416 1286109 156833 159515 412407 463516 0 0 62256 340380 429371 386838 51389 42533 9713853 11174637 0 0 0 0 12722154 13466690 1285898 1132799 263455 392404 0 81217 54888 77703 26018 1708273 1606109 X 9832692 10609911 1181189 1250670 11013881 11860581 12722154 13466690 -176182 1022882 0 X false true X true false X 423505 340380 381363 691828 429727 2266803 1430336 1805543 1230488 3178991 1456528 9101886 0 0 0 1853841 2145923 1611851 3870819 1886255 11368689 0 0 0 0 0 0 1198649 1504553 1069481 1609459 1260332 6642474 1198649 1504553 1069481 1609459 1260332 6642474 4726215 259708 227616 236788 281953 388872 1394937 0 259708 227616 236788 281953 388872 1394937 0 0 0 0 0 0 0 2113549 2373539 1848639 4152772 2275127 12763626 0.3703 0.5354 0.11 0.0794 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 8802 8802 0 240849 207848 33001 179720 170188 9532 42533 Rent Inducement 26018 26018 3437193 1022882 0 1022882 2414311 0 0 2414311 2550910 0 0 2550910 39583 39583 2590493 Schedule D, Part XII, Line 4(b) Other expenses in form 990 not in audited financial statements Congress Expenses - 39583 true North America (Canada & Mexico only) 1 18 Program Services Maintenance of office 1310690 North America (Canada & Mexico only) 0 0 Investments 11174637 East Asia and the Pacific 0 0 Grantmaking 89850 Europe (Including Iceland and Greenland) 0 0 Grantmaking 6200 Middle East and North Africa 0 0 Grantmaking 25000 North America (Canada & Mexico only) 0 0 Grantmaking 29648 South America 0 0 Grantmaking 14500 South Asia 0 0 Grantmaking 56452 Sub-Saharan Africa 0 0 Grantmaking 26000 1 18 0 0 1 18 12732977 0 12732977 South Asia Research 9000 Wire Transfer 1 0 Research East Asia and the Pacific 3 75000 Wire Transfer Travel Award East Asia and the Pacific 8 14850 Wire Transfer Travel Award Europe (Including Iceland and Greenland) 5 6200 Wire Transfer Research Middle East and North Africa 1 25000 Wire Transfer Travel Award North America (Canada & Mexico only) 11 4648 Wire Transfer Research North America (Canada & Mexico only) 1 25000 Wire Transfer Research South America 1 12500 Wire Transfer Travel Award South America 2 2000 Wire Transfer Research South Asia 2 40000 Wire Transfer Travel Award South Asia 5 7452 Wire Transfer Research Sub-Saharan Africa 1 25000 Wire Transfer Travel Award Sub-Saharan Africa 1 1000 Wire Transfer false false false false false false Schedule F, Part I, Line 2 Procedures for monitoring use of grant funds THE ORGANIZATION'S PROCESS FOR MONITORING THE USE OF GRANT FUNDS WHETHER IN THE US OR INTERNATIONALLY STARTS WITH THE SELECTION CRITERIA FOR EACH SUCH AWARD OR GRANT: RESEARCH FELLOWSHIPS ARE ONLY OFFERED TO A "FULL" MEMBER FOR A PERIOD OF 2 YEARS TO SUPPORT BASIC AND CLINICAL RESEARCH IN THE FIELD OF TRANSPLANTATION IN THE LABORATORY OR CLINICAL UNIT. FULL MEMBERS SHALL BE PHYSICIANS, SURGEONS, SCIENTISTS OR OTHER SPECIALISTS, WHO ARE ACTIVELY ENGAGED IN THE SCIENCE OR CLINICAL PRACTICE OF ORGAN, CELL AND TISSUE TRANSPLANTATION. PHYSICIANS AND SURGEONS SHALL HAVE ADVANCED TRAINING OR EQUIVALENT EXPERIENCE IN THE SCIENCE AND PRACTICE OF ORGAN AND TISSUE TRANSPLANTATION. NON-PHYSICIANS, INCLUDING COORDINATORS, STATISTICIANS, AND POLICY MAKERS WHO HOLD A DOCTORAL DEGREE, A BACHELOR'S DEGREE, OR EQUIVALENT RELEVANT CERTIFICATION MUST HAVE PROFESSIONAL EXPERIENCE IN THE FIELD OF TRANSPLANTATION WITH CONTINUING AND ACTIVE INVOLVEMENT IN CLINICAL MEDICINE OR RESEARCH, OR TRANSPLANTATION PUBLIC POLICY AS DETERMINED BY THE MEMBERSHIP COMMITTEE. THE PROCESS OF LIMITING RESEARCH FELLOWSHIPS ONLY TO FULL MEMBERS ALLOWS THE ORGANIZATION TO ENSURE THE RECIPIENTS HAVE THE PROPER CREDENTIALS TO USE THE FUNDS TO FURTHER THE ORGANIZATION'S TAX EXEMPT PURPOSES. THE FELLOWSHIPS ARE DESIGNED TO PROVIDE RESEARCH TRAINING FOR NEW YOUNG INVESTIGATORS WITH THE POTENTIAL OF MAKING A SIGNIFICANT CONTRIBUTION TO THE FIELD OF TRANSPLANTATION. IN ADDITION, THE AWARD RECIPIENT MUST TRAVEL TO THE CONFERENCE OR MEETING AND BE PHYSICALLY PRESENT IN ORDER TO RECEIVE THE FUNDING. Schedule F, Part I, Line 3 Method used to account for expenditures on org's financial statements EAST ASIA AND THE PACIFIC-Accrual; EUROPE (INCLUDING ICELAND AND GREENLAND)-Accrual; MIDDLE EAST AND NORTH AFRICA-Accrual; NORTH AMERICA (CANADA & MEXICO ONLY)-Accrual; SOUTH AMERICA-Accrual; SOUTH ASIA-Accrual; SUB-SAHARAN AFRICA-Accrual Schedule F, Part II, Line 1 Method used to account for expenditures on org's financial statements SOUTH ASIA-Accrual Schedule F, Part III Method used to account for expenditures on org's financial statements EAST ASIA AND THE PACIFIC -Accrual EUROPE (INCLUDING ICELAND AND GREENLAND) -Accrual MIDDLE EAST AND NORTH AFRICA -Accrual NORTH AMERICA (CANADA & MEXICO ONLY) -Accrual SOUTH AMERICA -Accrual SOUTH ASIA -Accrual SUB-SAHARAN AFRICA -Accrual true TRANSPLANT THERAPUETICS CONSORTIUM 1730 E RIVER ROAD TUCSON AZ 85718 201991334 501(c)(3) 15000 SPONSORSHIP OF WORKS 1 0 Research Fellowship 2 50000 Travel Awards 23 20900 Schedule I, Part I, Line 2 Procedures for monitoring use of grant funds. THE ORGANIZATION'S PROCESS FOR MONTORING THE USE OF GRANT FUNDS WHETHER IN THE US OR INTERNATIONALLY STARTS WITH THE SELECTION CRITERIA FOR EACH SUCH AWARD OR GRANT: 1) RESEARCH FELLOWSHIPS ARE ONLY OFFERED TO A "FULL" MEMBER FOR A PERIOD OF 2 YEARS TO SUPPORT BASIC AND CLINICAL RESEARCH IN THE FIELD OF TRANSPLANTATION IN THE LABORATORY OR CLINICAL UNIT. FULL MEMBERS SHALL BE PHYSICIANS, SURGEONS, SCIENTISTS OR OTHER SPECIALISTS, WHO ARE ACTIVELY ENGAGED IN THE SCIENCE OR CLINICAL PRACTICE OF ORGAN, CELL AND TISSUE TRANSPLANTATION. PHYSICIANS AND SURGEONS SHALL HAVE ADVANCED TRAINING OR EQUIVALENT EXPERIENCE IN THE SCIENCE AND PRACTICE OF ORGAN AND TISSUE TRANSPLANTATION. NON-PHYSICIANS, INCLUDING COORDINATORS, STATISTICIANS, AND POLICY MAKERS WHO HOLD A DOCTORAL DEGREE, A BACHELOR'S DEGREE, OR EQUIVALENT RELEVANT CERTIFICATION MUST HAVE PROFESSIONAL EXPERIENCE IN THE FIELD OF TRANSPLANTATION WITH CONTINUING AND ACTIVE INVOLVEMENT IN CLINICAL MEDICINE OR RESEARCH, OR TRANSPLANTATION PUBLIC POLICY AS DETERMINED BY THE MEMBERSHIP COMMITTEE. THE PROCESS OF LIMITING RESEARCH FELLOWSHIPS ONLY TO FULL MEMBERS ALLOWS THE ORGANIZATION TO ENSURE THE RECIPIENTS HAVE THE PROPER CREDENTIALS TO USE THE FUNDS TO FURTHER THE ORGANIZATION'S TAX EXEMPT PURPOSES. THE FELLOWSHIPS ARE DESIGNED TO PROVIDE RESEARCH TRAINING FOR NEW YOUNG INVESTIGATORS WITH THE POTENTIAL OF MAKING A SIGNIFICANT CONTRIBUTION TO THE FIELD OF TRANSPLANTATION. 2) SINCE THE MEDAWAR PRIZE AND THE RECOGNITION AWARDS ARE ONLY PRESENTED TO RECIPIENTS WHO MAKE OUTSTANDING CONTRIBUTIONS IN THE FIELD OF TRANSPLANTATION, THE SELECTION CRITERIA ENSURE THAT THE INVESTIGATOR(S) RECEIVING THESE GRANTS ARE AMONG THE MOST INFLUENTIAL IN THE FIELD OF ORGAN TRANSPLANTATION AND AS A RESULT THIS AWARD SUPPORTS THE FURTHERANCE OF THE ORGANIZATION'S MISSION. 3) TRAVEL GRANTS ARE PRESENTED TO YOUNG INVESTIGATORS OR THOSE WITH FINANCIAL DIFFICULTIES WHO ARE MEMBERS OF ORGANIZATION. PRIORITY IS GIVEN TO THOSE YOUNG INVESTIGATORS UNDER 40 YEARS OF AGE WITH THE FIRST AUTHORSHIP OF AN ACCEPTED ABSTRACT (ESPECIALLY THOSE FROM DEVELOPING COUNTRIES). AGAIN, THE REQUIREMENT THAT THE RECIPIENTS BE MEMBERS OF THE ORGANIZATION AND THE SELECTION CRITERIA ENABLE THE ORGANIZATION TO MONITOR THAT THE FUNDS WILL BE USED IN ACCORDANCE WITH ITS EXEMPT PURPOSE. Form 990, Part VI, Line 6 Classes of members or stockholders THE ORGANIZATION DOES NOT HAVE STOCKHOLDERS BUT DOES HAVE A 5 CATEGORIES OF MEMBERS: 1) FULL MEMBERS WHICH MUST BE PHYSICIANS, SURGEONS, SCIENTISTS OR OTHER SPECIALISTS, WHO ARE ACTIVELY ENGAGED IN THE SCIENCE OR CLINICAL PRACTICE OF ORGAN, CELL OR TISSUE TRANSPLANTATION. 2) TRAINEE MEMBERS SHALL INCLUDE INDIVIDUALS ENROLLED IN PRE OR POSTDOCTORAL TRAINING PROGRAMS RELEVANT TO THE SCIENCE AND CLINICAL PRACTICE OF ORGAN, CELL OR TISSUE TRANSPLANTATION, AND INDIVIDUALS WHO HAVE COMPLETED THEIR TRAINING BUT HAVE NOT YET QUALIFIED FOR FULL MEMBERSHIP. TRAINEE MEMBERS MAY NOT VOTE OR HOLD OFFICE ON THE COUNCIL BUT MAY SERVE ON THE COMMITTEES. 3) EMERITUS MEMBERSHIP SHALL BE FULL MEMBERS WHO HAVE ATTAINED THE AGE OF 65 OR HAVE RETIRED FRROM PRACTICE IN THE FIELD OF TRANSPLANTATION AND WHO FORMALLY REQUEST EDEMRITUS MEMBERSHIP. EMERITUS MEMBERS MAY NOT VOTE OR HOLD OFFICE ON THE COUNIL BUT MAY SERVE ON THE COMMITTEES AND SHALL BE EXEMPT FROM PAYMENT OF ANNUAL MEMBERSHIP DUES. 4) ASSOCIATE MEMBERS SHALL INCLUDE INDIVIDUALS WHO HAVE DEMONSTRATED A SUSTAINED AND CONTINUED INTEREST IN THE FIELD OF TRANSPLANTATION BUT WHO DO NOT QUALIFY FOR FULL OR TRAINEE MEMBERSHIP. THESE INDIVIDUALS MAY NOT VOTE, HOLD OFFICE, OR SERVE ON COMMITTEES BUT WILL HAVE ALL OTHER SOCIETAL PRIVILEGES (I.E. PHARMACEUTICAL REPRESENTATIVES). 5) HONORARY MEMBERS SHALL BE INVITED TO BECOME HONORARY MEMBERS BY THE COUNCIL OF THE SOCIETY AND SHALL BE INDIVIDUALS WITH A DISTINGUISHED RECORD IN TRANSPLANTATION IRRESPECTIVE OF PROFESSIONAL DISCIPLINE. HONORARY MEMBERS SHALL NOT HAVE THE RIGHT TO VOTE OR HOLD OFFICE ON THE COUNCIL AND SHALL BE EXEMPT FROM PAYMENT OF ANNUAL MEMBERSHIP DUES. A PERSON MAY APPLY TO BECOME A MEMBER BY SUBMITTING A COMPLETED APPLICATION ALONG WITH THE NECESSARY DOCUMENTATION AND THE WRITTEN RECOMMENDATION OF TWO MEMBERS. THE COUNCIL BY A VOTE OF A MAJORITY OF ITS MEMBERS SHALL APPROVE AND ELECT THE MEMBERS. Form 990, Part VI, Line 7a Members or stockholders electing members of governing body THE ORGANIZATION DOES HAVE MEMBERS WHO MAY ELECT MEMBERS OF THE GOVERNING BODY. IN ACCORDANCE WITH THE TERMS AND REQUIREMENTS OF ITS GOVERNING DOCUMENTS (I.E. BYLAWS), THE PRESIDENT, PRESIDENT-ELECT, AND PAST PRESIDENT SHALL SERVE FOR 2 YEARS; THE VICE PRESIDENT, THE SECRETARY , AND THE TRASURERS SHALL NORMALLY SERVE FOR 4 YEARS. THE FULL MEMBERS (AS DESCRIBED IN SCHEDULE O DESCRRIPTION FOR PART VI, QUESTION 6) RECEIVE ELECTION BALLOTS TO ELECT THESE BOARD OF DIRECTOR POSITIONS. Form 990, Part VI, Line 7b Decisions requiring approval by members or stockholders CERTAIN DECISIONS OF THE GOVERNING BODY ARE SUBJECT TO THE APPROVAL OF THE MEMBERS. IN ADDITION TO THE PRESIDENT, PRESIDENT-ELECT, PAST PRESIDENT, THE VICE PRESIDENT, THE SECRETARY, THE TREASURERS, THIRTEEN COUNCILORS-AT-LARGE REPRESENTING NORTH AMERICA, LATIN AMERICA, EUROPE, ASIA, AFRICA/MIDDLE EAST, AND OCEANIA SHALL SERVE AS THE COUNCIL OF THE SOCIETY, THUS CONSISTING OF NINETEEN PERSONS. ANY MAJOR DECISIONS OF THE ORGANIZATION MUST BE APPROVED BY MAJORITY VOTE BY THIS COUNCIL. THIS COUNCIL APPOINTS FULL MEMBERS TO SERVE ON STANDING OR SPECIAL COMMITTEES FROM TIME TO TIME TO DO SUCH THINGS AND HAVE SUCH POWERS AND SERVE UPON SUCH TERMS AS THE RESOLUTION ESTABLISHING THE COMMITTEE SHALL PROVIDE. ACTIONS OF ALL COMMITTEES SHALL BE SUBJECT TO REVIEW AND APPROVAL BY THE COUNCIL. Form 990, Part VI, Line 11b Review of form 990 by governing body BEFORE THE FORM 990 IS FILED IT IS REVIEWED BY THE ORGANIZATION'S EXECUTIVE DIRECTOR IN CONSULTATION WITH THE ORGANIZATION'S TAX ADVISORS, ERNST AND YOUNG, LLP. THE FINANCIAL REVIEW IS BASED ON THE ORGANIZATION'S AUDITED FINANCIAL STATEMENTS FOR THE RELEVANT TIME PERIOD. A COPY OF FORM 990 IS PROVIDED TO THE ORGANIZATION'S EXECUTIVE COMMITTEE PRIOR TO FILING WITH THE IRS. Form 990, Part VI, Line 12c Conflict of interest policy UPON EMPLOYMENT AND ANNUALLY THEREAFTER, EACH KEY EMPLOYEE AND OFFICER OF THE ORGANIZATION IS REQUIRED TO COMPLETE A CONFLICT OF INTEREST AND DISCLOSURE FORM, PROVIDING SUFFICIENT INFORMATION ABOUT HIS/HER PERSONAL INTERESTS AND RELATIONSHIPS SO THE THIRD PARTY PROVIDER CAN (1) DETERMINE WHETHER ANY POTENTIAL OR ACTUAL CONFLICTS OF INTEREST MAY EXIST, AND (2) MONITOR WORK OR SERVICE ASSIGNMENTS TO AVOID PLACING THE KEY EMPLOYEE, OFFICER OR DIRECTOR IN A POSITION WHERE THERE MAY BE AN APPEARANCE, POTENTIAL OR ACTUAL, OF A CONFLICT OF INTEREST OR A QUESTION OF OBJECTIVITY. Form 990, Part VI, Line 15a Process to establish compensation of top management official ON AN ANNUAL BASIS, THE EXECUTIVE COMMITTEE EVALUATES AND APPROVES THE CURRENT SALARY OF THE ORGANIZATION'S EXECUTIVE DIRECTOR. THIS EVALUATION PROCESS INCLUDES A REVIEW OF COMPARABLE DATA FOR THE POSITION OF EXECUTIVE DIRECTOR FROM TAX EXEMPT ORGANIZATIONS IN THE MARKET WITH SIMILAR SIZE, DEMOGRAPHICS AND GEOGRAPHY. Form 990, Part VI, Line 15b Process to establish compensation of other employees ON AN ANNUAL BASIS, THE EXECUTIVE COMMITTEE EVALUATES AND APPROVES THE CURRENT SALARY OF THE ORGANIZATION'S EXECUTIVE DIRECTOR. THIS EVALUATION PROCESS INCLUDES A REVIEW OF COMPARABLE DATA FOR THE POSITION OF EXECUTIVE DIRECTOR FROM TAX EXEMPT ORGANIZATIONS IN THE MARKET WITH SIMILAR SIZE, DEMOGRAPHICS AND GEOGRAPHY. Form 990, Part VI, Line 19 Required documents available to the public THE ORGANIZATION'S FINANCIAL STATEMENTS, GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST.